Advertisement
Screener

EDITAS MEDICINE, INC. (EDIT) Capital Expenditures Incurred but Not yet Paid

2.1 / 5 stars · 37/88 Roast Me

EDITAS MEDICINE, INC. Capital Expenditures Incurred but Not yet Paid

EDITAS MEDICINE, INC. (EDIT) reported Capital Expenditures Incurred but Not yet Paid of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-09.

Financial Statements › Cash Flow › Other Cash Flow Items

us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2026-03-09

  • EDITAS MEDICINE, INC. capital expenditures incurred but not yet paid for the quarter ending 2025-12-31 was $0.00.
  • EDITAS MEDICINE, INC. capital expenditures incurred but not yet paid for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
  • EDITAS MEDICINE, INC. capital expenditures incurred but not yet paid for the quarter ending 2025-06-30 was $0.00.
  • EDITAS MEDICINE, INC. capital expenditures incurred but not yet paid for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
  • EDITAS MEDICINE, INC. capital expenditures incurred but not yet paid for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
  • EDITAS MEDICINE, INC. capital expenditures incurred but not yet paid for fiscal 2024 was $65.00K, a 92.31% decline from fiscal 2023.
  • EDITAS MEDICINE, INC. capital expenditures incurred but not yet paid for fiscal 2023 was $845.00K, a 41.32% decline from fiscal 2022.
  • EDITAS MEDICINE, INC. capital expenditures incurred but not yet paid for fiscal 2022 was $1.44M, a 92.26% increase from fiscal 2021.
Period endCapital Expenditures Incurred but Not yet Paid 3 monthCapital Expenditures Incurred but Not yet Paid 6 monthCapital Expenditures Incurred but Not yet Paid 9 monthCapital Expenditures Incurred but Not yet Paid 12 month
2025-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09
$0.00
derived: sum of 2 quarters · filed 2026-03-09
$0.00
derived: sum of 3 quarters · filed 2026-03-09
$0.00
10-K · filed 2026-03-09
2025-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10
$0.00
derived: sum of 2 quarters · filed 2025-11-10
$0.00
10-Q · filed 2025-11-10
-$69.00K
derived: sum of 4 quarters · filed 2026-03-09
2025-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12
$0.00
10-Q · filed 2025-08-12
-$69.00K
derived: sum of 3 quarters · filed 2026-03-09
$11.00K
derived: sum of 4 quarters · filed 2026-03-09
2025-03-31$0.00
10-Q · filed 2025-05-12
-$69.00K
derived: sum of 2 quarters · filed 2026-03-09
$11.00K
derived: sum of 3 quarters · filed 2026-03-09
-$1.58M
derived: sum of 4 quarters · filed 2026-03-09
2024-12-31-$69.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09
$11.00K
derived: sum of 2 quarters · filed 2026-03-09
-$1.58M
derived: sum of 3 quarters · filed 2026-03-09
$65.00K
10-K · filed 2026-03-09
2024-09-30$80.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10
-$1.51M
derived: sum of 2 quarters · filed 2025-11-10
$134.00K
10-Q · filed 2025-11-10
$780.00K
derived: sum of 4 quarters · filed 2025-11-10
2024-06-30-$1.59M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12
$54.00K
10-Q · filed 2025-08-12
$700.00K
derived: sum of 3 quarters · filed 2025-08-12
$687.00K
derived: sum of 4 quarters · filed 2025-08-12
2024-03-31$1.64M
10-Q · filed 2025-05-12
$2.29M
derived: sum of 2 quarters · filed 2025-05-12
$2.28M
derived: sum of 3 quarters · filed 2025-05-12
$2.12M
derived: sum of 4 quarters · filed 2025-05-12
2023-12-31$646.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-05
$633.00K
derived: sum of 2 quarters · filed 2025-03-05
$475.00K
derived: sum of 3 quarters · filed 2025-03-05
$845.00K
10-K · filed 2025-03-05
2023-09-30-$13.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04
-$171.00K
derived: sum of 2 quarters · filed 2024-11-04
$199.00K
10-Q · filed 2024-11-04
$1.23M
derived: sum of 4 quarters · filed 2025-03-05
2023-06-30-$158.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07
$212.00K
10-Q · filed 2024-08-07
$1.24M
derived: sum of 3 quarters · filed 2025-03-05
$1.52M
derived: sum of 4 quarters · filed 2025-03-05
2023-03-31$370.00K
10-Q · filed 2024-05-08
$1.40M
derived: sum of 2 quarters · filed 2025-03-05
$1.68M
derived: sum of 3 quarters · filed 2025-03-05
$1.61M
derived: sum of 4 quarters · filed 2025-03-05
2022-12-31$1.03M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-05
$1.31M
derived: sum of 2 quarters · filed 2025-03-05
$1.24M
derived: sum of 3 quarters · filed 2025-03-05
$1.44M
10-K · filed 2025-03-05
2022-09-30$286.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03
$214.00K
derived: sum of 2 quarters · filed 2023-11-03
$413.00K
10-Q · filed 2023-11-03
$565.00K
derived: sum of 4 quarters · filed 2024-02-28
2022-06-30-$72.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02
$127.00K
10-Q · filed 2023-08-02
$279.00K
derived: sum of 3 quarters · filed 2024-02-28
-$203.00K
derived: sum of 4 quarters · filed 2024-02-28
2022-03-31$199.00K
10-Q · filed 2023-05-05
$351.00K
derived: sum of 2 quarters · filed 2024-02-28
-$131.00K
derived: sum of 3 quarters · filed 2024-02-28
$481.00K
derived: sum of 4 quarters · filed 2024-02-28
2021-12-31$152.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28
-$330.00K
derived: sum of 2 quarters · filed 2024-02-28
$282.00K
derived: sum of 3 quarters · filed 2024-02-28
$749.00K
10-K · filed 2024-02-28
2021-09-30-$482.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02
$130.00K
derived: sum of 2 quarters · filed 2022-11-02
$597.00K
10-Q · filed 2022-11-02
$343.00K
derived: sum of 4 quarters · filed 2023-02-22
2021-06-30$612.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03
$1.08M
10-Q · filed 2022-08-03
$825.00K
derived: sum of 3 quarters · filed 2023-02-22
$1.31M
derived: sum of 4 quarters · filed 2023-02-22
2021-03-31$467.00K
10-Q · filed 2022-05-04
$213.00K
derived: sum of 2 quarters · filed 2023-02-22
$694.00K
derived: sum of 3 quarters · filed 2023-02-22
$418.00K
derived: sum of 4 quarters · filed 2023-02-22
2020-12-31-$254.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22
$227.00K
derived: sum of 2 quarters · filed 2023-02-22
-$49.00K
derived: sum of 3 quarters · filed 2023-02-22
$656.00K
10-K · filed 2023-02-22
2020-09-30$481.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09
$205.00K
derived: sum of 2 quarters · filed 2021-11-09
$910.00K
10-Q · filed 2021-11-09
$866.00K
derived: sum of 4 quarters · filed 2022-02-24
2020-06-30-$276.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05
$429.00K
10-Q · filed 2021-08-05
$385.00K
derived: sum of 3 quarters · filed 2022-02-24
$1.06M
derived: sum of 4 quarters · filed 2022-02-24
2020-03-31$705.00K
10-Q · filed 2021-05-06
$661.00K
derived: sum of 2 quarters · filed 2022-02-24
$1.34M
derived: sum of 3 quarters · filed 2022-02-24
$1.08M
derived: sum of 4 quarters · filed 2022-02-24
2019-12-31-$44.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24
$632.00K
derived: sum of 2 quarters · filed 2022-02-24
$372.00K
derived: sum of 3 quarters · filed 2022-02-24
$728.00K
10-K · filed 2022-02-24
2019-09-30$676.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06
$416.00K
derived: sum of 2 quarters · filed 2020-11-06
$772.00K
10-Q · filed 2020-11-06
$755.00K
derived: sum of 4 quarters · filed 2021-02-26
2019-06-30-$260.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07
$96.00K
10-Q · filed 2020-08-07
$79.00K
derived: sum of 3 quarters · filed 2021-02-26
$384.00K
derived: sum of 4 quarters · filed 2021-02-26
2019-03-31$356.00K
10-Q · filed 2020-05-08
$339.00K
derived: sum of 2 quarters · filed 2021-02-26
$644.00K
derived: sum of 3 quarters · filed 2021-02-26
$886.00K
derived: sum of 4 quarters · filed 2021-02-26
2018-12-31-$17.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26
$288.00K
derived: sum of 2 quarters · filed 2021-02-26
$530.00K
derived: sum of 3 quarters · filed 2021-02-26
$659.00K
10-K · filed 2021-02-26
2018-09-30$305.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12
$547.00K
derived: sum of 2 quarters · filed 2019-11-12
$676.00K
10-Q · filed 2019-11-12
$1.06M
derived: sum of 4 quarters · filed 2020-02-26
2018-06-30$242.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07
$371.00K
10-Q · filed 2019-08-07
$760.00K
derived: sum of 3 quarters · filed 2020-02-26
$903.00K
derived: sum of 4 quarters · filed 2020-02-26
2018-03-31$129.00K
10-Q · filed 2019-05-08
$518.00K
derived: sum of 2 quarters · filed 2020-02-26
$661.00K
derived: sum of 3 quarters · filed 2020-02-26
$745.00K
derived: sum of 4 quarters · filed 2020-02-26
2017-12-31$389.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26
$532.00K
derived: sum of 2 quarters · filed 2020-02-26
$616.00K
derived: sum of 3 quarters · filed 2020-02-26
$623.00K
10-K · filed 2020-02-26
2017-09-30$143.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08
$227.00K
derived: sum of 2 quarters · filed 2018-11-08
$234.00K
10-Q · filed 2018-11-08
$120.00K
derived: sum of 4 quarters · filed 2019-03-01
2017-06-30$84.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07
$91.00K
10-Q · filed 2018-08-07
-$23.00K
derived: sum of 3 quarters · filed 2019-03-01
-$43.00K
derived: sum of 4 quarters · filed 2019-03-01
2017-03-31$7.00K
10-Q · filed 2018-05-04
-$107.00K
derived: sum of 2 quarters · filed 2019-03-01
-$127.00K
derived: sum of 3 quarters · filed 2019-03-01
-$389.00K
derived: sum of 4 quarters · filed 2019-03-01
2016-12-31-$114.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01
-$134.00K
derived: sum of 2 quarters · filed 2019-03-01
-$396.00K
derived: sum of 3 quarters · filed 2019-03-01
$130.00K
10-K · filed 2019-03-01
2016-09-30-$20.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08
-$282.00K
derived: sum of 2 quarters · filed 2017-11-08
$244.00K
10-Q · filed 2017-11-08
2016-06-30-$262.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09
$264.00K
10-Q · filed 2017-08-09
2016-03-31$526.00K
10-Q · filed 2017-05-15
2015-12-31$58.00K
10-K · filed 2018-03-08
2015-03-31$113.00K
10-Q · filed 2016-05-13

Similar stocks

Stock NameCountryMarket CapPE Ratio
Kyverna Therapeutics, Inc. (KYTX)United States$0.434B-3.60
Scribe Therapeutics, Inc. (SCTX)United States$0.410B
Eikon Therapeutics, Inc. (EIKN)United States$0.446B
Zura Bio Ltd (ZURA)$0.398B-6.56
Surrozen, Inc./DE (SRZN)United States$0.395B
AGENUS INC (AGEN)United States$0.383B1.41
Tectonic Therapeutic, Inc. (TECX)United States$0.469B-7.68
C4 Therapeutics, Inc. (CCCC)United States$0.373B-5.65
FENNEC PHARMACEUTICALS INC. (FENC)United States$0.371B-115.85
REGENXBIO Inc. (RGNX)United States$0.477B-3.30